US Patent 11912750 GDNF fusion polypeptides and methods of use thereof
Patent 11912750 was granted and assigned to Keros Therapeutics on February, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11912750 GDNF fusion polypeptides and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
